Mette Rosenkilde
Professor
Molecular Pharmacology
Blegdamsvej 3, 2200 København N, 18.5, Building: 22
Mette Rosenkilde is professor at the Department of Biomedical Sciences (BMI). She is head of the Molecular Pharmacology Laboratory (MolPharm) where the common research theme is the relationship between structure and function of 7TM (seven transmembrane segment), G protein-coupled receptors.
Possible conflicts of interest
Professor Mette Rosenkilde is co-founder of different start-ups:
- Inagen (2007)
- Antag Therapeutics (2016)
- Synklino (2017)
- Bainan (2018)
MolPharm/BMI collaborates with Antag Therapeutics, Bainan Biotech and Synklino on a variety of research projects with the aim of generating new knowledge that can be used in the prevention and treatment of diseases.
Mette Rosenkilde does not receive salary from any of the companies.
ID: 3361
Most downloads
-
506
downloads
Pharmacokinetics of oral and intravenous melatonin in healthy volunteers
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
475
downloads
Differential CCR7 Targeting in Dendritic Cells by Three Naturally Occurring CC-Chemokines
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
340
downloads
Attenuation of chemokine receptor function and surface expression as an immunomodulatory strategy employed by human cytomegalovirus is linked to vGPCR US28
Research output: Contribution to journal › Journal article › Research › peer-review
Published